NCT05362331

Feasibility of a "Companion for CAR-T" Web App During Chimeric Antigen Receptor T-cell Therapy

Study Summary

The complex logistics and unique toxicities of chimeric antigen receptor T-cell (CAR-T) therapy require intensive patient education and careful monitoring. The Companion for CAR-T (CC) web app may be able to assist with patient education and preparation, communication between patients and their multidisciplinary teams, and home-based toxicity monitoring.

Want to learn more about this trial?

Request More Info

Interventions

Web ApplicationOTHER
Internet based application

Study Locations

No locations listed.

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026